NCT02015559View on ClinicalTrials.gov

Mucoadhesive Oral Wound Rinse in Preventing and Treating Stomatitis in Patients With ER- or PR-Positive Metastatic or Locally Recurrent Breast Cancer That Cannot be Removed by Surgery Receiving Everolimus

PHASE2CompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

October 8, 2014

Primary Completion Date

November 30, 2018

Study Completion Date

November 30, 2018

Conditions
Estrogen Receptor-positive Breast CancerHER2-negative Breast CancerOral ComplicationsProgesterone Receptor-positive Breast CancerRecurrent Breast CancerStage IIIB Breast CancerStage IIIC Breast CancerStage IV Breast Cancer
Interventions
DRUG

mucoadhesive oral wound rinse

Given PO

OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (1)

90095

Jonsson Comprehensive Cancer Center, Los Angeles

All Listed Sponsors
collaborator

Translational Research in Oncology

OTHER

lead

Jonsson Comprehensive Cancer Center

OTHER

NCT02015559 - Mucoadhesive Oral Wound Rinse in Preventing and Treating Stomatitis in Patients With ER- or PR-Positive Metastatic or Locally Recurrent Breast Cancer That Cannot be Removed by Surgery Receiving Everolimus | Biotech Hunter | Biotech Hunter